Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

NCT06159790

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sandoz Investigational Site Fountain Valley, California, United States
  • Sandoz Investigational Site Banja Luka, Bosnia and Herzegovina
  • Sandoz Investigational Site Sarajevo, Bosnia and Herzegovina
  • Sandoz Investigational Site Zenica, Bosnia and Herzegovina
View all 62 locations
View Trial Details
Completed

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

NCT05077709

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
Locations
  • City of Hope Duarte, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • University of California San Diego San Diego, California, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 21 locations
View Trial Details
Completed

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

NCT05110196

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Novartis Investigative Site Gujarat, India
  • Novartis Investigative Site Mangalore, Karnataka, India
  • Novartis Investigative Site Thalassery, Kerala, India
  • Novartis Investigative Site Trivandrum, Kerala, India
View all 15 locations
View Trial Details
Completed

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

NCT02087423

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Research Site Goodyear, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Port Saint Lucie, Florida, United States
View all 139 locations
View Trial Details

Related conditions